CBCT vs OPT on the Oral Health Status at 12 Months of Patients Hospitalized for Infective Endocarditis.
NCT ID: NCT06269679
Last Updated: 2025-09-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
170 participants
INTERVENTIONAL
2024-12-18
2028-07-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Thus, conducting a randomized controlled trial is highly desirable to assess the potential impact of a clinical examination/CBCT approach on the oral health status of patients hospitalized for IE and potentially to reduce IE new episodes.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Interest of the Cone-beam Computed Tomography in the Imagery of the Middle Ear
NCT02896764
International PRospective Multicenter Study On RadiaTion Dose Estimates Of Coronary CT AngIOgraphy IN Daily Practice
NCT00610766
Safety and Performance of Optivantage Multi-use When Injecting Contrast Media for Contrast Enhanced CT Examination
NCT05537779
PET CT in Suspected CIED Infection, a Pilot Study - PET Guidance I
NCT02196753
Effect of Different Voxel Sizes on Accuracy of CBCT Linear Measurements: Preclinical Study
NCT03229018
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
OPT
Orthopantomogram = current recommended clinical examination approach (comparator procedure)
No interventions assigned to this group
CBCT
Cone Beam Computed Tomography = experimental clinical examination approach (procedure under evaluation)
CBCT
Cone Beam Computed Tomography (CBCT) has a better sensitivity and sensibility to detect OIF.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CBCT
Cone Beam Computed Tomography (CBCT) has a better sensitivity and sensibility to detect OIF.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patients with a stable clinical state, meaning stabilized IE patients out of the critical phase, compatible with the performance of an OPT and a CBCT;
3. Patients whose life expectancy is expected to be longer than 6 months;
4. Patients who agree to visit the dental department of the hospital to carry out OIF eradication or at his/her personal dentist;
5. Patients over 18 years old;
6. Patients affiliated to a Social Security or a health insurance scheme;
7. Patients who have given informed consent to participate to the study.
Exclusion Criteria
2. Medical contraindications to perform OPT or CBCT imaging;
3. Absence of microbiologic identification of the IE responsible microorganism;
4. Pregnant or breastfeeding women;
5. Patients unable to give informed consent to participate to the study (under trusteeship, guardianship and legal protection).
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nantes University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Bordeaux - Site Pellegrin
Bordeaux, , France
CHU Clermont-Ferrand
Clermont-Ferrand, , France
CHU Grenoble
Grenoble, , France
HCL
Lyon, , France
APHM
Marseille, , France
CHRU Nancy
Nancy, , France
CHU Nantes
Nantes, , France
AP-HP - Site Bretonneau
Paris, , France
CHU Toulouse
Toulouse, , France
CHRU Tours
Tours, , France
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Magali VIDAL
Role: primary
Sarah MILLOT GUARD
Role: primary
Jean-Hugues CATHERINE
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RC23_0336
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.